/NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN/
HALIFAX, Jan. 15, 2018 /CNW/ - Christopher Dobbin ("Dobbin") announced today that he has been granted 800,000 options to purchase common shares ("Stock Options") of Nova Leap Health Corp. (TSXV: NLH) ("Nova Leap"), with its head office at 104-37 Wentworth Street, Dartmouth, Nova Scotia, B2Y 2S9. The Stock Options are exercisable for a period of 10 years at an exercise price of $0.25 per common share of Nova Leap (the "Common Shares") and vest 25% immediately and 25% on each anniversary date of the Stock Option grant date, January 12, 2018.
The Stock Options were granted under and are subject to the terms and conditions of Nova Leap's Stock Option plan, Nova Leap's long-term incentive plan for its personnel and consultants. Dobbin may acquire, dispose of, or continue to hold Common Shares and/or Stock Options in the normal course of his investment activities.
Dobbin acquired ownership of 800,000 Stock Options, which, if exercised, represent approximately 2.43% of the Common Shares issued and outstanding.
Immediately before the granting of the Stock Options, Dobbin owned 485,000 Stock Options, which, if exercised, represented approximately 1.49% of all issued and outstanding Common Shares.
Following the granting of the Stock Options, Dobbin now owns 1,285,000 Stock Options, which, if exercised, represent approximately 3.85% of all issued and outstanding Common Shares.
SOURCE Christopher Dobbin
Renseignements: Further details on the information above may be obtained from the Early Warning Report filed on SEDAR or by contacting Christopher Dobbin at 902-401-9480.